Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

5.66
Delayed Data
As of May 24
 -0.21 / -3.58%
Today’s Change
4.72
Today|||52-Week Range
14.59
+1.07%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close5.87
Today’s open5.60
Day’s range5.58 - 5.95
Volume42,630
Average volume (3 months)140,200
Market cap$143.7M
Dividend yield--
Data as of 05/24/2017

Growth & Valuation

Earnings growth (last year)+18.45%
Earnings growth (this year)+3.94%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+140.14%
P/E ratio--
Price/Sales5.59
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
EVGNEvogene Ltd0.000.00%
PSTIPluristem Therapeuti...0.000.00%
KDMNKadmon Holdings Inc+0.10+4.05%
ADVMAdverum Biotechnolog...+0.02+0.92%
Data as of 05/24/2017

Financials

Next reporting dateAugust 25, 2017
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$25.1M
Annual profit (last year)-$73.4M
Net profit margin-292.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts